DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy

New genetic testing could spare 6,600 UK breast cancer patients annually from unnecessary chemotherapy while maintaining equivalent survival rates. International…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Mental health interventions show promise for extreme weather trauma recovery

Mental health interventions demonstrate significant effectiveness in reducing PTSD, depression, and anxiety symptoms among people affected by extreme weather events.…

Experimental Drug Shows 96% Viral Suppression in Hepatitis B Clinical Trial

Clinical trial shows experimental drug bepirovirsen achieves 96% viral suppression when combined with standard hepatitis B therapy. Phase III trials…

World’s Largest Longevity Competition Targets Age Reversal Breakthroughs

The XPRIZE Healthspan competition offers $101 million in prizes for age reversal breakthroughs targeting cognitive, muscle, and immune function. Dr.…

Lab-grown brain organoids reveal how to reverse ‘irreversible’ nerve damage

Cambridge researchers used lab-grown brain organoids to discover that human neurons lose regenerative capacity during development, but thyroid hormone therapy…

Phase 3 Trial of Bepirovirsen Shows Promise for Chronic Hepatitis B Treatment

Phase 3 clinical trial results for bepirovirsen, a novel antisense oligonucleotide therapy for chronic hepatitis B, published in The New…

Weight Loss Expert Raises Safety Concerns Over Unregulated GLP-1 ‘Microdoses’

Weight-loss specialist warns about unregulated GLP-1 microdosing trend lacking clinical trial evidence. Long-term safety effects remain unknown for reduced-dose formulations.

Non-surgical vision correction technique could challenge LASIK dominance

Researchers have developed a breakthrough vision correction technique using platinum contact lenses and electrical pulses that could reshape the cornea…

Moldova probation centres identify 136 people with opioid disorders through innovative screening programme

Research across 10 Moldovan probation centres identified 136 people with opioid use disorder among 900 participants, with 97% treatment retention…

GMJ BriefsView all →